Protalix Ltd.
Records under this name other than the patents Protalix Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,225,648 | Modified Dnase and Uses Thereof Lapsed on the fee record Ended Jan 18, 2026 · High confidence | Lapsed on the fee record | Ended Jan 18, 2026 | High confidence |
| US 8,790,641 | Production of High Mannose Proteins in Plant Culture and Therapeutic Uses Thereof Term ended Term ended Oct 18, 2025 · High confidence | Term ended | Term ended Oct 18, 2025 | High confidence |
| US 7,951,557 | Human Lysosomal Proteins from Plant Cell Culture Term ended Ended no later than Jul 1, 2025 · Medium confidence | Term ended | Ended no later than Jul 1, 2025 | Medium confidence |
| US 10,730,925 | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same Lapsed on the fee record Ended Aug 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 4, 2024 | From the USPTO record |
| US 8,227,230 | Human lysosomal proteins from plant cell culture Term ended Term ended Feb 24, 2024 · From the USPTO record | Term ended | Term ended Feb 24, 2024 | From the USPTO record |
| US 8,741,620 | Human lysosomal proteins from plant cell culture Term ended Term ended Feb 24, 2024 · From the USPTO record | Term ended | Term ended Feb 24, 2024 | From the USPTO record |
| US 9,220,737 | Plant cell culture expressing human lysosomal proteins and uses thereof Term ended Term ended Feb 24, 2024 · From the USPTO record | Term ended | Term ended Feb 24, 2024 | From the USPTO record |
| US 8,119,406 | System and method for production of antibodies in plant cell culture Lapsed on the fee record Ended Feb 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2024 | From the USPTO record |
| US 10,087,232 | Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy Formerly held Lapsed on the fee record Ended Oct 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 2, 2022 | From the USPTO record |
| US 10,000,551 | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same Lapsed on the fee record Ended Jun 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2022 | From the USPTO record |